Please Wait
Applying Filters...
Menu
Xls
2D Structure
Also known as: Facinicline [inn], Facinicline free base, 677306-35-3, 6a6fx0j03k, Chembl2151439, 677306-35-3 (free base)
Molecular Formula
C15H18N4O
Molecular Weight
270.33  g/mol
InChI Key
TXCYUSKWBHUVEP-CYBMUJFWSA-N
FDA UNII
6A6FX0J03K

1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
N-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-1H-indazole-3-carboxamide
2.1.2 InChI
InChI=1S/C15H18N4O/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18)/t13-/m1/s1
2.1.3 InChI Key
TXCYUSKWBHUVEP-CYBMUJFWSA-N
2.1.4 Canonical SMILES
C1CN2CCC1C(C2)NC(=O)C3=NNC4=CC=CC=C43
2.1.5 Isomeric SMILES
C1CN2CCC1[C@@H](C2)NC(=O)C3=NNC4=CC=CC=C43
2.2 Other Identifiers
2.2.1 UNII
6A6FX0J03K
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. Facinicline [inn]

2. Facinicline Free Base

3. 677306-35-3

4. 6a6fx0j03k

5. Chembl2151439

6. 677306-35-3 (free Base)

7. 1h-indazole-3-carboxamide, N-(3s)-1-azabicyclo(2.2.2)oct-3-yl-

8. N-((3s)-1-azabicyclo(2.2.2)octan-3-yl)-1h-indazole-3-carboxamide

9. (s)-n-(quinuclidin-3-yl)-1h-indazole-3-carboxamide

10. Unii-6a6fx0j03k

11. N-[(3s)-1-azabicyclo[2.2.2]octan-3-yl]-1h-indazole-3-carboxamide

12. Rg 3487

13. Mem63908

14. Rg3487 Free Base

15. Schembl45329

16. Facinicline [who-dd]

17. Mem3454 Free Base

18. Rg-3487 Free Base

19. Mem 3454 Free Base

20. Mem-3454 Free Base

21. Dtxsid90218011

22. Ro-5313534 Free Base

23. Bdbm50393245

24. Zinc34057058

25. Db05586

26. Q27264402

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 270.33 g/mol
Molecular Formula C15H18N4O
XLogP31.8
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count3
Rotatable Bond Count2
Exact Mass270.14806121 g/mol
Monoisotopic Mass270.14806121 g/mol
Topological Polar Surface Area61 Ų
Heavy Atom Count20
Formal Charge0
Complexity380
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

Investigated for use/treatment in alzheimer's disease, neurologic disorders, and schizophrenia and schizoaffective disorders.